ATE187066T1 - Verwendung von cholin oder cholin freisetzenden verbindungen zur verringerung der empfingdung von ermüdung - Google Patents

Verwendung von cholin oder cholin freisetzenden verbindungen zur verringerung der empfingdung von ermüdung

Info

Publication number
ATE187066T1
ATE187066T1 AT86113026T AT86113026T ATE187066T1 AT E187066 T1 ATE187066 T1 AT E187066T1 AT 86113026 T AT86113026 T AT 86113026T AT 86113026 T AT86113026 T AT 86113026T AT E187066 T1 ATE187066 T1 AT E187066T1
Authority
AT
Austria
Prior art keywords
choline
fatigue
releasing compounds
sensation
reduce
Prior art date
Application number
AT86113026T
Other languages
English (en)
Inventor
Richard J Wurtman
Lydia Conlay
Krzyoztof Blusztajn
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE187066T1 publication Critical patent/ATE187066T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT86113026T 1985-09-28 1986-09-22 Verwendung von cholin oder cholin freisetzenden verbindungen zur verringerung der empfingdung von ermüdung ATE187066T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/780,053 US4626527A (en) 1985-09-28 1985-09-28 Process for utilizing choline to sustain muscular performance

Publications (1)

Publication Number Publication Date
ATE187066T1 true ATE187066T1 (de) 1999-12-15

Family

ID=25118425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86113026T ATE187066T1 (de) 1985-09-28 1986-09-22 Verwendung von cholin oder cholin freisetzenden verbindungen zur verringerung der empfingdung von ermüdung

Country Status (5)

Country Link
US (1) US4626527A (de)
EP (1) EP0217258B1 (de)
JP (1) JPH0657654B2 (de)
AT (1) ATE187066T1 (de)
DE (1) DE3650735T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001117A (en) * 1989-03-07 1991-03-19 Pharmacaps, Inc. Use of lecithin to restore olfaction and taste
FR2673512B1 (fr) * 1991-03-05 1993-08-20 Inst Rech Biolog Sa Nouvelles compositions dietetiques a base de lipides complexes phosphores et leur utilisation dans les troubles du sommeil.
WO1994009769A1 (en) * 1992-11-02 1994-05-11 Buchman Alan L Use of choline in total parenteral nutrition
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink
US6013273A (en) * 1997-01-27 2000-01-11 Novartis Nutrition Ag Treatment of endotoxic shock
US20040086564A1 (en) * 2002-10-31 2004-05-06 Richardson Paul H. Dosage forms containing stabilized choline and method for preparing same
CA2619145A1 (en) * 2005-08-16 2007-02-22 Alan L. Buchman Use of choline to prevent thrombosis associated with total parenteral nutrition
US20210212936A1 (en) * 2018-06-01 2021-07-15 Baxter International Inc. Parenteral nutrition formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB879259A (en) * 1956-11-20 1961-10-11 Riker Laboratories Inc Acid addition salts of 2-dimethylaminoethanol and central nervous system stimulant compositions containing them
US4456598A (en) * 1977-11-02 1984-06-26 Massachusetts Institute Of Technology Process and composition for treating disorders by administering a butyrophenone and a choline
CA1114295A (en) * 1977-11-02 1981-12-15 John H. Growdon Process and composition for treating disorders by administering choline or a compound that dissociates to choline
DE2915433A1 (de) * 1979-04-17 1980-10-30 Christensen Plantorgan Werk Verwendung von physiologisch vertraeglichen methyldonatoren
DE3346525C2 (de) * 1983-12-22 1987-03-19 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-glycero-3-phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich

Also Published As

Publication number Publication date
DE3650735T2 (de) 2000-05-11
JPH0657654B2 (ja) 1994-08-03
DE3650735D1 (de) 2000-01-05
EP0217258A2 (de) 1987-04-08
US4626527A (en) 1986-12-02
JPS62111920A (ja) 1987-05-22
EP0217258A3 (de) 1989-12-13
EP0217258B1 (de) 1999-12-01

Similar Documents

Publication Publication Date Title
ATE219674T1 (de) Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika
DE3851203D1 (de) Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.
HUT62798A (en) Process for producing pharmaceutical composition with slimming activity
ES2033434T3 (es) Composicion cosmetica.
EP0151989A3 (en) Means for the treatment of cardiac diseases
ATE78171T1 (de) Gangliosidgemisch zur verwendung als therapeutisches hilfsmittel zur schmerzunterdrueckung bei peripheren neuropathien.
DK0631772T3 (da) Retinoidholdig sammensætning
ATE187066T1 (de) Verwendung von cholin oder cholin freisetzenden verbindungen zur verringerung der empfingdung von ermüdung
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
IE871567L (en) Method for treating depression
IT1237519B (it) Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
Smith et al. The aging process: Benefits of physical activity
EP0147185A3 (de) Therapeutische Verwendung von Cytidyl-Diphosphocholin für Steigerung von Neuronal-Acetylcholin
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
Spankus et al. Hypnosis in cerebral palsy
DE69821970D1 (de) Verwendung von CITICOLINE ZUR BEHANDLUNG VON MULTIPLER SKLEROSE
KR920011502A (ko) 인체 신경계의 통증을 치료할 수 있는 부자이중탕(附子理中湯)의 개량된 한방치료제 물질
DE19902003A1 (de) Verfahren zur Verbesserung der körperlichen Erscheinung
Hick Occupational therapy in a hospital for rheumatic diseases
Formby Shiatsu message for carers
IT1229058B (it) Attrezzo da ginnastica per prevenire, curare, migliorare la salute e l'aspetto del corpo umano
Kulik Functional relationships between the respiratory muscles and muscles performing dynamic work
Küppers The RYODORAKU SYSTEM OBJECTIVE CONTROL OF COMMON DISEASES AND NEUROSIS IN PARTICULAR
Lieske Employee Fitness and Recreation
Kostić Zajednički tretman bračnih partnera.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee